Incomplete Conflict of Interest Disclosures
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmaceutical industry and healthcare · Healthcare cost, quality, practices · Patient Dignity and Privacy
In 4 articles published in JAMA Network Open between 2018 and 2021,^1,2,3,4^ conflict of interest disclosures for David B. Abrams, PhD, and Raymond S. Niaura, PhD, were omitted or incomplete. These authors have provided additional disclosures, which include the following. For Dr Abrams, “other NIDA grants paid to his employers; receiving salary from the Steven Schroeder Institute for Tobacco Research and Policy Studies at The Legacy Foundation, now Truth Initiative, New York University School of Global Public Health; and between mid-2015 and 2020, frequently communicating with Juul Labs personnel, for which there was no compensation, and receiving hospitality in the form of meals at some meetings.” For Dr Niaura, “serving as a paid consultant to the Government of Canada via a contract with Industrial Economics Inc; receiving an honorarium for a virtual meeting from Pfizer Inc; receiving other NIDA grants paid to his employers; receiving salary from the Steven Schroeder Institute for Tobacco Research and Policy Studies at The Legacy Foundation, now Truth Initiative, New York University School of Global Public Health; and between mid-2015 and 2020, frequently communicating with Juul Labs personnel, for which there was no compensation, and receiving hospitality in the form of meals at some meetings.” These articles have been corrected to include these additional disclosures.^1,2,3,4^
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Abrams DB, Notley C. Is nicotine reduction in cigarettes enough? JAMA Netw Open. 2020;3(10):e 2019367. doi:10.1001/jamanetworkopen.2020.1936733079192 · doi ↗ · pubmed ↗
- 2Pearson JL, Sharma E, Rui N, . Association of electronic nicotine delivery system use with cigarette smoking progression or reduction among young adults. JAMA Netw Open. 2020;3(11):e 2015893. doi:10.1001/jamanetworkopen.2020.1589333231634 PMC 7686868 · doi ↗ · pubmed ↗
- 3Goniewicz ML, Smith DM, Edwards KC, . Comparison of nicotine and toxicant exposure in users of electronic cigarettes and combustible cigarettes. JAMA Netw Open. 2018;1(8):e 185937. doi:10.1001/jamanetworkopen.2018.593730646298 PMC 6324349 · doi ↗ · pubmed ↗
- 4Kasza KA, Edwards KC, Kimmel HL, . Association of e-cigarette use with discontinuation of cigarette smoking among adult smokers who were initially never planning to quit. JAMA Netw Open. 2021;4(12):e 2140880. doi:10.1001/jamanetworkopen.2021.4088034962556 PMC 8715340 · doi ↗ · pubmed ↗